Coronary artery disease trials in China
291 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 4Not yet taking people in ChinaIMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI
- Where
- Xuzhou
- Age
- 18 years to 75 years
- People
- 3,300
- Run by
- The Affiliated Hospital of Xuzhou Medical University
See details and how to joinNCT07875179 - No phaseTaking peopleAbbott Vascular Medical Device Registry
- Where
- Jinhua, Ningbo, Xi’an
- Age
- 18 years and over
- People
- 3,784 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT04573660 - Phase 4Taking peopleEffect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Where
- Beijing
- Age
- 18 years and over
- People
- 116
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07657676 - No phaseEnrolling by invitationInfluencing Factors and Outcomes of DCB Angioplasty
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 5,000
- Run by
- Henan Institute of Cardiovascular Epidemiology
See details and how to joinNCT06620458 - No phaseTaking peopleGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Dalian
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - Phase 4Taking peopleCAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
- Where
- Chengdu, Xi'an
- Age
- 40 years to 75 years
- People
- 232
- Run by
- West China Hospital
See details and how to joinNCT07612774 - No phaseNot yet taking people in ChinaOPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI)
- Where
- Hangzhou, Yuhuan, Zhoushan
- Age
- 18 years to 80 years
- People
- 554
- Run by
- Zhejiang Hospital
See details and how to joinNCT07855614 - No phaseTaking peoplepCAD-POAF 3 Year Follow-up
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 430
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07146061 - Phase 4Taking peoplePrecision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
- Where
- Shenyang
- Age
- 40 years to 85 years
- People
- 120
- Run by
- Shenyang Northern Hospital
See details and how to joinNCT07362966 - No phaseTaking peopleAspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
- Where
- Changchun
- Age
- 18 years to 85 years
- People
- 2,640
- Run by
- Jilin University
See details and how to joinNCT07846462 - No phaseTaking peopleImpact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion
- Where
- Changchun
- Age
- 18 years and over
- People
- 150
- Run by
- Jilin University
See details and how to joinNCT07853261 - No phaseNot yet taking people in ChinaIntranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions
- Where
- Hangzhou
- Age
- 45 years to 85 years
- People
- 2,500
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07847580 - No phaseTaking peopleDrug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 1,244
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06742125 - No phaseNot yet taking people in ChinaReal-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure
- Where
- Jinan, Tianjin
- Age
- 40 years to 80 years
- People
- 200
- Run by
- China Academy of Chinese Medical Sciences
See details and how to joinNCT07841275 - No phaseTaking peopleThe FAVOR V AMI Trial
- Where
- Beijing
- Age
- 18 years and over
- People
- 5,000
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT05669222 - No phaseTaking peopleA Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation
- Where
- Beijing
- Age
- 18 years and over
- People
- 10,000
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07766434 - No phaseTaking peoplePost-Marketing Clinical Study of High-Pressure Cutting Balloon
- Where
- Xi’an
- Age
- 18 years and over
- People
- 280
- Run by
- BrosMed Medical Co., Ltd
See details and how to joinNCT07835178 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Baotou Shi, Beijeing, Beijing, Chengdu, Dalian, Deyang Shi, Dongguan, Foshan Shi, Guangzhou, Hefei, Jiaxing, Lanzhou, Luoyang Shi, Mianyang, Nanchang, Nanjing, Nanning, Pingxiang, Shanghai, Shanghai Shi, Shenzhen, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuxi, Xiamen, Xianyang, Xinxiang, Yangzhou, Yibin, Zhengzhou, Zhenjiang
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleSTICH3C Cardiac Magnetic Resonance Observational Study
- Where
- Shanghai
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07133984 - Phase 2Taking peopleEffect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 160
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06548204 - Phase 3Taking peopleEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- Where
- Beijing, Fuzhou, Guangzhou, Jining, Luoyang, Nanchang, Shanghai, Tianjin, Wenzhou, Xuzhou
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07102628 - No phaseTaking peoplePCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Beijing Chao Yang Hospital
See details and how to joinNCT07822737 - No phaseTaking peopleThrombus Aspiration in STEMI Patients With High Thrombus Burden
- Where
- Changsha, Chengdu, Foshan, Fuzhou, Ganzhou, Guangzhou, Guilin, Haikou, Huizhou, Jiangmen, Kaiping, Kashgar, Kunming, Maoming, Shantou, Shaoguan, Shaoxing, Shenzhen, Taishan, Ürümqi, Weifang, Wenzhou, Wuhan, Xi’an, Xiongzhou, Yangjiang, Zhanjiang, Zhaoqing, Zhongshan, Zhuhai
- Age
- 18 years and over
- People
- 3,838
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT04212494 - No phaseTaking peopleManual Thrombus Aspiration During PCI in STEMI With Angiographically Evident Thrombus
- Where
- Changsha
- People
- 3,500
- Run by
- Shenghua Zhou
See details and how to joinNCT06654453 - No phaseNot yet taking people in ChinaYiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
- Where
- Guangzhou, Jinan, Tianjin, Zhengzhou
- Age
- 40 years to 80 years
- People
- 100
- Run by
- China Academy of Chinese Medical Sciences
See details and how to joinNCT07803471